top of page

Interest subsidy on existing SME loans affected by COVID-19

COVID-19 - Επιδότηση επιτοκίου.png
Information sheet for submitting applications for financing investment projects in the Action

The new Action "Interest subsidy for existing loans to small and medium-sized enterprises affected by the measures to deal with the COVID-19 virus pandemic"  aims to support companies affected by the pandemic, in the form of covering the interest on their business loan obligations for a period of 3 months.

Submission Period:

Start of Submissions: 15  April  2020

Closing of Submissions: 30  June  2020

Eligible program KAD

Beneficiaries of the Action:

Beneficiaries of the aid  are Small and Medium Enterprises, regardless of

their legal form, operating legally in the country.

Enhancement

 

In this action the public funding amounts to 100%.

Basic Conditions for Participation

   Businesses should:  

  • To be active on 19/03/2020 in the eligible sectors of activity (KAD) mentioned in Annex V of this announcement.

  • To have the status of Small and Medium Enterprise.

  • Do not constitute problematic companies on 31/12/2019.

  • To commit that they will employ the same number of staff on 31/12/2020 that they employed on 19/03/2020.

Subsidized Expenses

​​

Eligible costs are:

  • The contractual interest as well as the corresponding contribution of law 128/75 of the loans of the eligible companies, and in particular regular business loans, bond loans and Credit Agreements, including:

  • Securitized loans and credits (article 10 of law 3156/2003),

  • Loans and credits transferred due to sale. These loans must be up to date on 31/12/2019.

The loan agreements for which the company is selected for this action must have been concluded before 01/04/2020.

​​

ΚΑΔ.jpg

THE  Ependysis Business Consultants , with executives who have previously evaluated and not only submitted NSRF investment proposals, can successfully undertake the submission as well as the monitoring of your investment plan.

 

For more information call the company phones: 2112155988 or emailinfo@ependysis.eu  .

bottom of page